Market Data on Cardiovascular and Diabetes

Published within

« | 1 | » »|

Type Product title / description Pub Price
Interactive Model
Interactive Model

Antidiabetics market forecast

Analysis of the competitive landscape and the recent changes in antidiabetics across seven major markets. Analysis of the threats to currently marketed drugs. Assessment of the opportunities available to novel agent classes.

Published By Datamonitor
17 Sep 2010 $15400
Buy
Interactive Model
Interactive Model

Testosterone Replacement Therapy Market Forecast

In-depth analysis of the current and future testosterone replacement therapy prescription market across the seven major markets (US, Japan, France, Germany, Italy, Spain, UK), supported by key opinion leader insight.

Published By Datamonitor
27 Sep 2010 $15200
Buy
Interactive Model
Interactive Model

Commercial Insight: Cardiovascular and Metabolic Market Forecast

In-depth review of the cardiovascular and metabolic markets, including analysis and comparison of key sales trends in the therapy areas of diabetes, dyslipidemia, hypertension and thrombosis over the forecast (2010–19) period.

Published By Datamonitor
08 Feb 2011 $6400
Buy
Databook
Databook

Company Financials: Shire plc

In-depth Company Financials with Key Ratios, and Revenue details by segments and geographies for the last five years download the attached datapack (.xls file)

Published By Datamonitor
17 Feb 2011 $75
Buy
Databook
Databook

Company Financials: King Pharmaceuticals, Inc.

In-depth Company Financials with Key Ratios, and Revenue details by segments and geographies for the last five years download the attached datapack (.xls file)

Published By Datamonitor
17 Feb 2011 $75
Buy
Databook
Databook

Company Financials: Xoma Ltd.

In-depth Company Financials with Key Ratios, and Revenue details by segments and geographies for the last five years download the attached datapack (.xls file)

Published By Datamonitor
08 Apr 2011 $75
Buy
Interactive Model
Interactive Model

The Dyslipidemia Market Forecast to 2021

In the wake of Lipitor’s patent expiry, the dyslipidemia market continues to face increasing genericization leading to falling sales in key drug classes.

Published By Datamonitor
04 Feb 2013 $6400
Buy
Interactive Model
Interactive Model

Medtrack: Cardiovascular Pipeline Databook - May 2013

This in-depth Excel databook covers the cardiovascular pipeline by company and phase.

Published By Datamonitor
31 May 2013 $2900
Buy
Interactive Model
Interactive Model

Medtrack: Metabolic and Endocrinology Pipeline Databook - May 2013

This in-depth Excel databook covers the metabolic and endocrinology pipeline by company and phase.

Published By Datamonitor
31 May 2013 $2900
Buy

« | 1 | » »|

No help is available.